NFE2L2 and COVID-19: However, in recent studies, SARS-CoV-2 infection enabled to inhibit the Nrf2 pathway, as observed in biopsies from COVID-19 patients (Olagnier et al., 2020; Zhang et al., 2022a; Zhang et al., 2022b).